These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27067220)

  • 1. [Development of mesangial immunoglobulin IgA glomerulonephritis and p-ANCA positivity in a patient with psoriatic arthritis].
    Nazzaro P; Battaglia R; D'Altri C; Marangi AL; Perniola M; Rodio A; De Padova F
    G Ital Nefrol; 2016; 33(2):. PubMed ID: 27067220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesangial immunoglobulin (Ig)A glomerulonephritis in a patient with rheumatoid arthritis treated with abatacept.
    Michel M; Henri P; Vincent FB; Leon N; Marcelli C
    Joint Bone Spine; 2013 Dec; 80(6):660-3. PubMed ID: 23816503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracapillary glomerulonephritis during etanercept treatment for juvenile psoriatic arthritis.
    Menè P; Franeta AJ; Conti G; Stoppacciaro A; Chimenz R; Fede A; Gallizzi R; Fede C
    Clin Exp Rheumatol; 2010; 28(1):91-3. PubMed ID: 20346246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Berger's disease associated to an adalimumab-treated rheumatoid arthritis].
    Pierrot A; Combe C; Lepelley M; Brucker M; Constant E
    Ann Pharm Fr; 2018 Nov; 76(6):499-503. PubMed ID: 30146149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis.
    Stokes MB; Foster K; Markowitz GS; Ebrahimi F; Hines W; Kaufman D; Moore B; Wolde D; D'Agati VD
    Nephrol Dial Transplant; 2005 Jul; 20(7):1400-6. PubMed ID: 15840673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANCA-positive crescentic glomerulonephritis in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor alpha.
    Alkhunaizi AM; Dawamneh MF
    Int J Rheum Dis; 2017 Nov; 20(11):1843-1847. PubMed ID: 26012729
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
    Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
    Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].
    Haake H; Köneke J; Amann K; vom Dahl J; Janssen U
    Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis.
    Chandran V; Shen H; Pollock RA; Pellett FJ; Carty A; Cook RJ; Gladman DD
    J Rheumatol; 2013 Jun; 40(6):866-71. PubMed ID: 23637322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of adalimumab, etanercept, golimumab and infliximab in rheumatic pathologies: variation between label dosage and real-world use.
    Martinez-Cutillas J; Alerany-Pardo C; Borrás-Blasco J; Broto-Sumalla A; Burgos-SanJosé A; Climent-Bolta C; Escudero-Vilaplana V; Fernández-Fuente MA; Ferrit-Martin M; Gómez-Germá P; Martínez-Sesmero JM; Mayorga-Pérez J; Menchén-Viso B; Merino-Alonso J; Polache-Vengud J; Sánchez-Guerrero A
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(5):851-8. PubMed ID: 25972066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with etanercept of a patient with psoriatic arthritis after adalimumab-related hepatotoxicity.
    Massarotti M; Marasini B
    Int J Immunopathol Pharmacol; 2009; 22(2):547-9. PubMed ID: 19505409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
    Perrotta FM; Marchesoni A; Lubrano E
    J Rheumatol; 2016 Feb; 43(2):350-5. PubMed ID: 26669925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoimmune aspects of treatment with TNF-alpha inhibitors].
    Kolarz B; Targońska-Stepniak B; Darmochwał-Kolarz D; Majdan M
    Postepy Hig Med Dosw (Online); 2007 Aug; 61():478-84. PubMed ID: 17786135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained clinical response in psoriatic arthritis patients treated with anti-TNF agents: a 5-year open-label observational cohort study.
    Saougou I; Markatseli TE; Papagoras C; Voulgari PV; Alamanos Y; Drosos AA
    Semin Arthritis Rheum; 2011 Apr; 40(5):398-406. PubMed ID: 20843542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANCA-associated renal vasculitis following anti-tumor necrosis factor alpha therapy.
    Simms R; Kipgen D; Dahill S; Marshall D; Rodger RS
    Am J Kidney Dis; 2008 Mar; 51(3):e11-4. PubMed ID: 18295046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of IGA antigliadin antibodies during primary glomerulonephritis with mesangial IGA deposits].
    Rostoker G; Delprato S; Benmaadi A; Petit-Phar M; Andre C; Laurent J; Lang P; Weil B; Lagrue G
    Ann Med Interne (Paris); 1989; 140(7):571-4. PubMed ID: 2610450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis and disease activity in subjects with psoriatic arthritis receiving tumor necrosis factor-α blockers.
    Di Minno MN; Iervolino S; Peluso R; Russolillo A; Lupoli R; Scarpa R; Di Minno G; Tarantino G;
    J Rheumatol; 2012 May; 39(5):1042-6. PubMed ID: 22422493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double Infection in a Patient with Psoriatic Arthritis Under TNF-alpha Blockers Therapy: A Case Report.
    Caroleo B; Migliore A; Cione E; Zampogna S; Perticone F; Sarro G; Gallelli L
    Curr Drug Saf; 2019; 14(2):147-150. PubMed ID: 30648521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.